Cyprotex has joined forces with parent company, Evotec, a leader in the field of transcriptomics. Understanding the role of transcriptomics in drug-induced toxicity is a key focus for the team.
In a recent study published in Nature Communications, a team of researchers at the Carl R. Woese Institute for Genomic ...
Transcriptomics might one day help forensic scientists predict time of death Cells continue to function even after an individual dies. That's according to a scientific study published in Nature ...
Study uses spatial transcriptomics to map intratumoral heterogeneity and microenvironmental dynamics in triple-negative ...
and spatial transcriptomics (ST) on subcortical multiple sclerosis (MS) and control tissues to map cell types, interactions, and pathways in the lesion and non-lesion areas. They identified ...
We study cell fate decisions; why a cell survives through a perturbation that kills many other cells? We explore this in the context of high-grade serous ovarian cancer that typically becomes ...
The information you provide will be shared with the sponsors of this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You ...
Here, we used deep full-length single-cell RNA-sequencing to distinguish post-mitotic cone and rod developmental states and cone-specific features that contribute to retinoblastomagenesis. The ...
Complete Genomics will share details of various multi-omics and spatial transcriptomics applications based on its sequencing technology at the 2024 American Society of Human Genetics (ASHG) Meeting.
In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?